Details of the Drug Reposition

General Information of This Drug (ID: DMREQCF)

Drug Name
CAR-T Cells targeting EpCAM   DMREQCF
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
6 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Esophageal cancer DISGB2VN 2B70 Phase 1/2 [1]
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1/2 [1]
Colon cancer DISVC52G 2B90.Z Phase 1/2 [1]
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
Hepatocellular carcinoma DIS0J828 2C12.02 Phase 1/2 [1]
Prostate cancer DISF190Y 2C82.0 Phase 1/2 [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Metastatic cancer DISBPS35 2D50-2E2Z Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03013712) A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
2 ClinicalTrials.gov (NCT03563326) Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)